Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre, Open, Uncontrolled Study to Assess Quality of Life During Six Cycles (24 Weeks) of Treatment With an Oral Contraceptive Containing 30 µg of Ethinylestradiol and 3 mg of Drospirenone (Yasmin).

NCT00367276 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00367276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00367276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre, Open, Uncontrolled Study to Assess Quality of Life During Six Cycles (24 Weeks) of Treatment With an Oral Contraceptive Containing 30 µg of Ethinylestradiol and 3 mg of Drospirenone (Yasmin).
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2002
Completion date
May 31, 2004
Enrollment
221 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

healthy